0001209191-19-003550.txt : 20190114
0001209191-19-003550.hdr.sgml : 20190114
20190114163415
ACCESSION NUMBER: 0001209191-19-003550
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190110
FILED AS OF DATE: 20190114
DATE AS OF CHANGE: 20190114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ambrogi Michael J.
CENTRAL INDEX KEY: 0001654363
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 19525368
MAIL ADDRESS:
STREET 1: 195 COMMERCE WAY
CITY: PORTSMOUTH
STATE: NH
ZIP: 03801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-10
0
0001645113
NovoCure Ltd
NVCR
0001654363
Ambrogi Michael J.
C/O NOVOCURE INC.
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Operating Officer
Ordinary Shares
2019-01-10
4
M
0
54930
14.37
A
201488
D
Ordinary Shares
2019-01-10
4
S
0
20880
40.469
D
180608
D
Ordinary Shares
2019-01-10
4
S
0
34050
41.14
D
146558
D
Options to Buy Ordinary Shares
14.37
2019-01-10
4
M
0
54930
0.00
D
2025-02-23
Ordinary Shares
54930
37391
D
These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.
On January 10, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,880 shares in multiple trades at prices ranging from $40.00 to $40.99. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 10, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 34,050 shares in multiple trades at prices ranging from $41.00 to $41.45. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Fully vested as of the date hereof.
/s/ Kimberly Burke, Attorney in fact for Michael J. Ambrogi
2019-01-14